CZMGX vs. ECAT
CZMGX (Multi-Manager Growth Strategies Fund) and ECAT (BlackRock ESG Capital Allocation Term Trust) are both mutual funds - CZMGX is a Large Cap Growth Equities fund managed by BlackRock, while ECAT is a Tactical Allocation fund managed by BlackRock. Over the past 3 years, CZMGX returned 22.02%/yr vs 19.97%/yr for ECAT. A 0.70 correlation means they provide meaningful diversification when combined. CZMGX charges 0.74%/yr vs 1.43%/yr for ECAT.
Performance
CZMGX vs. ECAT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CZMGX achieves a 7.04% return, which is significantly lower than ECAT's 14.09% return.
CZMGX
- 1D
- 1.58%
- 1M
- -2.93%
- YTD
- 7.04%
- 6M
- 7.04%
- 1Y
- 17.07%
- 3Y*
- 22.02%
- 5Y*
- 11.93%
- 10Y*
- —
ECAT
- 1D
- 0.13%
- 1M
- 1.47%
- YTD
- 14.09%
- 6M
- 14.09%
- 1Y
- 19.81%
- 3Y*
- 19.97%
- 5Y*
- —
- 10Y*
- —
CZMGX vs. ECAT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CZMGX Multi-Manager Growth Strategies Fund | 7.04% | 15.18% | 34.55% | 41.78% | -29.41% | 3.56% |
ECAT BlackRock ESG Capital Allocation Term Trust | 14.09% | 16.64% | 19.96% | 32.36% | -21.90% | -6.25% |
Correlation
The correlation between CZMGX and ECAT is 0.62, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.62 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.65 |
Correlation (All Time) Calculated using the full available price history since Sep 28, 2021 | 0.70 |
The correlation between CZMGX and ECAT has been stable across timeframes, ranging from 0.62 to 0.70 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CZMGX vs. ECAT — Risk / Return Rank
CZMGX
ECAT
CZMGX vs. ECAT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Multi-Manager Growth Strategies Fund (CZMGX) and BlackRock ESG Capital Allocation Term Trust (ECAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CZMGX | ECAT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.49 | ||
| Sortino ratioReturn per unit of downside risk | -0.71 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.26 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.96 | 1.69 | -0.73 |
| Martin ratioReturn relative to average drawdown | 3.03 | 6.26 | -3.23 |
Loading charts...
Drawdowns
CZMGX vs. ECAT - Drawdown Comparison
The maximum CZMGX drawdown since its inception was -35.23%, which is greater than ECAT's maximum drawdown of -32.23%. Use the drawdown chart below to compare losses from any high point for CZMGX and ECAT.
Loading charts...
Drawdown Indicators
| CZMGX | ECAT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.23% | -32.23% | -3.00% |
Max Drawdown (1Y)Largest decline over 1 year | -16.55% | -11.80% | -4.75% |
Max Drawdown (3Y)Largest decline over 3 years | -22.71% | -15.79% | -6.92% |
Max Drawdown (5Y)Largest decline over 5 years | -35.23% | — | — |
Current DrawdownCurrent decline from peak | -2.93% | 0.00% | -2.93% |
Average DrawdownAverage peak-to-trough decline | -7.56% | -8.99% | +1.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.21% | 3.17% | +2.04% |
Volatility
CZMGX vs. ECAT - Volatility Comparison
Multi-Manager Growth Strategies Fund (CZMGX) has a higher volatility of 7.09% compared to BlackRock ESG Capital Allocation Term Trust (ECAT) at 4.76%. This indicates that CZMGX's price experiences larger fluctuations and is considered to be riskier than ECAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CZMGX | ECAT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.09% | 4.76% | +2.33% |
Volatility (6M)Calculated over the trailing 6-month period | 13.18% | 11.12% | +2.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.79% | 13.90% | +2.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.71% | 16.88% | +4.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.86% | 16.88% | +4.98% |
CZMGX vs. ECAT - Expense Ratio Comparison
CZMGX has a 0.74% expense ratio, which is lower than ECAT's 1.43% expense ratio.
Dividends
CZMGX vs. ECAT - Dividend Comparison
CZMGX has not paid dividends to shareholders, while ECAT's dividend yield for the trailing twelve months is around 21.39%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CZMGX Multi-Manager Growth Strategies Fund | 0.00% | 11.02% | 10.86% | 5.59% | 10.39% | 15.19% | 5.04% | 5.53% | 6.87% | 4.66% |
ECAT BlackRock ESG Capital Allocation Term Trust | 21.39% | 23.00% | 17.44% | 9.14% | 8.94% | 0.54% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CZMGX and ECAT have a correlation of 0.62, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CZMGX has higher volatility (7.09%) compared to ECAT (4.76%). In terms of maximum drawdown, CZMGX dropped -35.23% vs ECAT's -32.23%.
ECAT currently has the higher Sharpe Ratio (1.44 vs 0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CZMGX and ECAT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer